Modeling and the Use of Surrogate Endpoints: Is This a Valid Approach?

Related articles

1. LLM-assisted evidence audit of late-stage cancer incidence as a screening trial endpoint

   This article has 10 authors:

   1. Shiyin Li
   2. Wanheng Zhang
   3. Xing Xing
   4. Ziyuan Shen
   5. Yining Wang
   6. Zhao Chen
   7. Onicio Batista Leal Neto
   8. Yulin Yu
   9. Chong Wu
   10. Lifeng Lin

2. Performance of general-population breast cancer risk prediction models in an international consortium

   This article has 45 authors:

   1. Kristen D. Brantley
   2. Thomas U. Ahearn
   3. Emily L. Norton
   4. Robert MacInnis
   5. Julie R. Palmer
   6. Renée T. Fortner
   7. Celine M. Vachon
   8. Laura Beane-Freeman
   9. Amy Berrington de Gonzalez
   10. Reuben Frost
   11. Kimberly A. Bertrand
   12. Gary Zirpoili
   13. Marian L. Neuhouser
   14. Matthew Barnett
   15. Lauren R. Teras
   16. James M. Hodge
   17. Alpa V. Patel
   18. Clara Bodelon
   19. James V. Lacey
   20. Emma S. Spielfogel
   21. Thomas E. Rohan
   22. Victoria A. Kirsh
   23. Hilde Langseth
   24. Kaitlyn M. Tsuruda
   25. Roger L. Milne
   26. Christopher Haiman
   27. Christopher G. Scott
   28. A. Heather Eliassen
   29. Bernard Rosner
   30. Walter C. Willett
   31. Andrea Romanos-Nanclares
   32. Yu Chen
   33. Fen Wu
   34. Wei Zheng
   35. Jirong Long
   36. Katie M. O’Brien
   37. Dale P. Sandler
   38. Cari M. Kitahara
   39. Martha S. Linet
   40. Garnet Anderson
   41. Joseph C. Larson
   42. I-Min Lee
   43. Montserrat Garcia-Closas
   44. Nilanjan Chatterjee
   45. Peter Kraft

3. CHARMS and PROT+AI: an updated template for Data Extraction and Risk of Bias Assessment in systematic reviews of prediction models

   This article has 4 authors:

   1. A. Jaber
   2. L.T. Hughes
   3. A.C. Cameron
   4. T.J. Quinn